IOVA
NASDAQ · Biotechnology
Iovance Biotherapeutics Inc
$3.46
-0.09 (-2.54%)
Open$3.52
Previous Close$3.55
Day High$3.57
Day Low$3.42
52W High$5.63
52W Low$1.64
Volume—
Avg Volume16.75M
Market Cap1.62B
P/E Ratio—
EPS$-1.12
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+1,482.9% upside
Current
$3.46
$3.46
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 344.48M | 337.04M | 333.93M |
| Net Income | -511,108,720 | 23.64M | 18.09M |
| Profit Margin | -148.4% | 7.0% | 5.4% |
| EBITDA | -480,323,540 | 42.24M | 40.52M |
| Free Cash Flow | — | 21.56M | 19.96M |
| Rev Growth | — | +17.4% | +6.9% |
| Debt/Equity | 0.00 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |